Eledon Pharmaceuticals (ELDN) Net Income (QoQ) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Eledon Pharmaceuticals | 419.90 Mn | 203.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 22.90% |
| Jun 30, 2025 | -37.68% |
| Mar 31, 2025 | -146.81% |
| Dec 31, 2024 | 287.09% |
| Sep 30, 2024 | -41.43% |
| Jun 30, 2024 | -33.43% |
| Mar 31, 2024 | -232.73% |
| Dec 31, 2023 | 173.13% |
| Sep 30, 2023 | -8.15% |
| Jun 30, 2023 | 6.80% |
| Mar 31, 2023 | 80.97% |
| Dec 31, 2022 | -457.58% |
| Sep 30, 2022 | -13.24% |
| Jun 30, 2022 | 6.26% |
| Mar 31, 2022 | -134.92% |
| Dec 31, 2021 | 387.76% |
| Sep 30, 2021 | -32.95% |
| Jun 30, 2021 | 13.12% |
| Mar 31, 2021 | -30.73% |
| Dec 31, 2020 | -5.81% |
| Sep 30, 2020 | -137.59% |
| Jun 30, 2020 | 68.37% |
| Mar 31, 2020 | -96.23% |
| Dec 31, 2019 | -42.71% |
| Sep 30, 2019 | 28.59% |
| Jun 30, 2019 | 16.12% |
| Mar 31, 2019 | -6.51% |
| Dec 31, 2018 | -30.81% |
| Sep 30, 2018 | -9.72% |
| Jun 30, 2018 | -14.10% |
| Mar 31, 2018 | -32.78% |
| Dec 31, 2017 | 29.01% |
| Sep 30, 2017 | 55.52% |
| Jun 30, 2017 | -390.51% |
| Mar 31, 2017 | 63.63% |
| Dec 31, 2016 | -136.67% |
| Sep 30, 2016 | -78.82% |
| Jun 30, 2016 | 92.27% |
| Mar 31, 2016 | -3.71% |
| Dec 31, 2015 | 7.05% |
| Sep 30, 2015 | -32.33% |
| Jun 30, 2015 | 32.45% |
| Mar 31, 2015 | -113.60% |
| Dec 31, 2014 | 2.85% |
| Sep 30, 2014 | -9.21% |
| Jun 30, 2014 | -20.71% |
| Mar 31, 2014 | 12.65% |
| Dec 31, 2013 | -64.90% |